Antiglaucomatosos tópicos y obstrucción de la vía lagrimal
Barra lateral del artículo
Contenido principal del artículo
Downloads
Detalles del artículo
Sección
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
Nerad J A. Cirugía oculoplástica. Los requisitos en Oftalmología. Madrid: Elsevier; 2002. p. 216-8.
Tanenbaum M, McCord CD. Lacrimal drainage system. In: Tasman W(editor). Duane’s clinical ophthalmology. Vol. 4. Revised ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001. p. 1-34. 2.
Nemet AY. The Etiology of Epiphora: A Multifactorial Issue. Semin Ophthalmol. 2016; 31(3): 275-9. DOI: https://doi.org/10.3109/08820538.2014.962163
American Academy of Ophtalmology. Órbita, párpados y aparato lagrimal. Madrid: Elsevier; 2008. p. 272, 284
Kashkouli MB, Sadeghipour A, Kaghazkanani R, et al. Pathogenesis of primary acquired nasolacrimal duct obstruction. Orbit. 2010; 29(1): 11-15. DOI: https://doi.org/10.3109/01676830903207828
Kashkouli MB, Parvaresh MM, Mirzajani H, et al. Intraoperative Mitomycin C Use During Filtration Surgery and Lacrimal Drainage System Obstruction. Am J Ophthalmol. 2009; 147(3): 453-7. DOI: https://doi.org/10.1016/j.ajo.2008.08.037
McNab AA. Lacrimal canalicular obstruction associated with topical ocular medication. Aust N Z J Ophthalmol. 1998; 26(3): 219-23. DOI: https://doi.org/10.1111/j.1442-9071.1998.tb01315.x
Lee AJ, Mitchell P, Rochtchina E, et al. Female reproductive factors and open-angle glaucoma: the Blue Mountains Eye Study. Br J Ophthalmol. 2003; 87: 1324 -32. DOI: https://doi.org/10.1136/bjo.87.11.1324
Bahmani-Kashkouli M, Rezaee R, Nilforushan N, et al. Topical anti-glaucoma medications and lacrimal drainage system obstruction. Iran J Ophthalmol. 2008; 20(2): 20-6.
Aydin Kurna S, Acikgoz S, Altun A, et al. The Effects of Topical Antiglaucoma Drugs as Monotherapy on the Ocular Surface: A Prospective Study. J Ophthalmol. 2014; 2014: 1-8 DOI: https://doi.org/10.1155/2014/460483